Exploring brain stimulation effects on cognitive impairment in Parkinson's disease
Official title: Effect and Mechanism of Deep Brain Stimulation and Transcranial Magnetic Stimulation on Parkinson's Disease With Cognitive Impairment
Run by Tianjin Huanhu Hospital · NCT06090682 · Data updated 2026-11-12
This study is testing how brain stimulation treatments can help improve thinking and memory problems in people with Parkinson's disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Tianjin Huanhu Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Status | Recruiting |
| Started | November 1, 2023 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2027 |
| Registry record updated | October 19, 2023 |
| Trial ID | NCT06090682 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Parkinson's disease for over five years who exhibit cognitive impairment and are eligible for deep brain stimulation.
✕Probably not a fit
Patients with severe cognitive impairment, psychiatric disorders, or atypical parkinsonism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the effects of deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) on cognitive impairment in patients with Parkinson's disease (PD). Utilizing advanced neuroimaging techniques, the study will analyze structural and functional brain network changes before and after treatment. By examining the relationship between neural regulation and cognitive symptoms, the research seeks to identify optimal stimulation sites and improve clinical outcomes for PD patients. The findings could provide insights into the mechanisms underlying cognitive decline in Parkinson's disease.
Why it matters
Potential benefit: If successful, this study could lead to improved cognitive function in Parkinson's disease patients through targeted brain stimulation techniques.
How similar studies have gone: Previous studies have shown promising results with brain stimulation techniques in improving cognitive symptoms in Parkinson's disease, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. The clinical diagnosis of PD is consistent with the United Kingdom Parkinson's Disease Society Brain Bank criteria, with disease duration over 5 years, acute levodopa motor response ≥30%, and indication for STN-DBS. Exclusion Criteria: Exclusion criteria included patients with severe cognitive impairment, severe psychiatric disorders, acute levodopa motor response less than 30%, atypical parkinsonism, and contraindications to surgery.
Where it's running
-
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: Zhao Guangrui, doctor
- Email: Guangrui-Zhao@hotmail.com
- Phone: +86 18956405513
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
-
Theta stimulation to enhance cognitive function in Parkinson's disease
This study is testing if a special type of brain stimulation can help improve thinking skills in people with Parkinson's disease.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.